60
Participants
Start Date
December 13, 2019
Primary Completion Date
September 10, 2021
Study Completion Date
September 10, 2021
AMG 171
2 SAD cohorts of 8 subjects per cohort randomized 3:1 in Part A; 1 cohort of 8 subjects 3:1 ratio in Part B; and 24 subjects enrolled into 1 of 3 cohorts with 8 subjects randomized to receive 2 to 3 consecutive doses (titration) 3:1 ratio in Part C.
Placebo
AMG 171 placebo
Clinical Pharmacology of Miami, LLC, Miami
Orange County Research Center, Tustin
Anaheim Clinical Trials, Anaheim
Lead Sponsor
Amgen
INDUSTRY